Parvovirus B19 infection - An emerging infectious disease?

Israel Medical Association Journal

Volumn 4, Issue 10, 2002, Pages 810-811

  Rahav, Galia ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Erythema infectiosum; Parvovirus B19; Polymerase chain reaction

Indexed keywords

ANTIBODY; GLOBOSIDE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOGLOBULIN M ANTIBODY; INTERLEUKIN 6; PROTEIN; PROTEIN ANTIBODY; PROTEIN VP1; PROTEIN VP1 ANTIBODY; PROTEIN VP2; PROTEIN VP2 ANTIBODY; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; VIRUS ANTIBODY; VIRUS DNA;

ACUTE LYMPHOBLASTIC LEUKEMIA; ANEMIA; ANTIBODY DETECTION; ANTIBODY PRODUCTION; APLASIA; APOPTOSIS; ARTHRITIS; ARTHROPATHY; ASSAY; AUTOIMMUNITY; BLACKFAN DIAMOND ANEMIA; BLOOD SAMPLING; BONE MARROW; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; DNA HYBRIDIZATION; EDITORIAL; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; ERYTHEMA INFECTIOSUM; ERYTHROBLAST; ERYTHROCYTE; ERYTHROID CELL; ERYTHROID PRECURSOR CELL; ERYTHROPOIESIS; FETUS DEATH; FETUS HYDROPS; FEVER; GENETIC ASSOCIATION; HEMOPHAGOCYTIC SYNDROME; HEPATITIS; HUMAN; IMMUNE COMPLEX DISEASE; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFECTION RATE; INTERSTITIAL LUNG DISEASE; LEUKOCYTOCLASTIC VASCULITIS; MALAISE; MEGAKARYOCYTE; NONHUMAN; OPTIC NERVE DISEASE; PARVOVIRUS; POLYARTHRITIS; POLYMERASE CHAIN REACTION; PUBLIC HEALTH; RADIOIMMUNOASSAY; RASH; SEROLOGY; SEROPREVALENCE; SPONTANEOUS ABORTION; SYSTEMIC LUPUS ERYTHEMATOSUS; VERTICAL TRANSMISSION; VIREMIA; VIRUS CULTURE; VIRUS IDENTIFICATION; VIRUS INFECTION; VIRUS RESISTANCE;

ACUTE DISEASE; ADULT; ANEMIA; ANTIBODIES, VIRAL; ARTHRITIS; CHILD; DIAGNOSIS, DIFFERENTIAL; DNA, VIRAL; ERYTHEMA INFECTIOSUM; FEMALE; FEVER; HUMANS; IMMUNOGLOBULIN M; LUNG DISEASES, INTERSTITIAL; MALE; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POLYMERASE CHAIN REACTION; PREGNANCY; TIME FACTORS;

EID: 0036791403     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (25)

1. Brown K. Parvovirus B19. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th edn. Philadelphia: Churchill Livingstone, 2000:1685-93.
2. Anand A, Gray ES, Brown T, Clewley JP, Cohen BJ. Human parvovirus infection in pregnancy and hydrops fetalis. N Engl J Med 1987;316(4):183-6.
3. Barah F, Vallely PJ, Chiswick ML, Cleator GM, Kerr JR. Association of human parvovirus B19 infection with acute meningoencephalitis. Lancet 2001;358:729-30.
4. Walsh KJ, Armstrong RD, Turner AM. Brachial plexus neuropathy associated with human parvovirus infection. Br Med J 1988;296:896.
5. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S. Human parvovirus B19 infection associated with acute hepatitis. Lancet 1996;347:868-9.
6. Janner D, Bork J, Baum M, Chinnock R. Severe pneumonia after heart transplantation as a result of human parvovirus B19. J Heart Lung Transplant 1994;13(2):336-8.
7. Enders G, Dotsch J, Bauer J, et al. Life-threatening parvovirus B19-associated myocarditis and cardiac transplantation as possible therapy: two case reports. Clin Infect Dis 1998;26(2):355-8.
8. Passoni LF, Ribeiro SR, Giordani ML, Menezes JA, Nascimento JP. Papular-purpuric "gloves and socks" syndrome due to parvovirus B19: report of a case with unusual features. Rev Inst Med Trop Sao Paulo 2001;43(3):167-70.
9. Broliden K. Parvovirus B19 infection in pediatric solid-organ and bone marrow transplantation. Pediatr Transplant 2001;5(5):320-30.
10. Diaz F, Collazos J, Mendoza F, et al. Systemic lupus erythematosus associated with acute parvovirus B19 infection. Clin Microbiol Infect 2002;8(2):115-17.
11. Kerr JR, Cartron JP, Curran MD, Moore JE, Elliot JR, Mollan RA. A study of the role of parvovirus B19 in rheumatoid arthritis. Br J Rheumatol 1995;34(9):809-13.
12. Leruez-Ville M, Lauge A, Morinet F, Guillevin L, Deny P. Polyarteritis nodosa and parvovirus B19. Lancet 1994;344:263-4.
13. Heegaard ED, Rosthoj S, Petersen BL, et al. Role of parvovirus B19 infection in childhood idiopathic thrombocytopenic purpura. Acta Paediatr 1999;88(6):614-17.
14. Takeda S, Takaeda C, Takazakura E, Haratake J. Renal involvement induced by human parvovirus B19 infection. Nephron 2001;89(3):280-5.
15. Cohen BJ. Human parvovirus B19 infection in Kawasaki disease. Lancet 1994;344:59.
16. Klar A, Halamish A, Shoseyov D, et al. Chronic human parvovirus B19 infection associated with interstitial lung disease. IMAJ 2002;4:825-6.
17. Barash J, Dushnitzky D, Sthoeger D, Bardenstein R, Barak Y. Human parvovirus B19 infection in children: uncommon clinical presentations. IMAJ 2002;4:763-5.
18. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993;262:114-17.
19. Moffatt S, Tanaka N, Tada K, et al. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J Virol 1996;70(12):8485-91.
20. Tolfvenstam T, Ruden U, Broliden K. Evaluation of serological assays for identification of parvovirus B19 immunoglobulin M. Clin Diagn Lab Immunol 1996;3(2):147-50.
21. Kurtzman GJ, Cohen BJ, Field AM, Oseas R, Blaese RM, Young NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989;84(4):1114-1123.
22. Patou G, Pillay D, Myint S, Pattison J. Characterization of a nested polymerase chain reaction assay for detection of parvovirus B19. J Clin Microbiol 1993;31(3):540-6.
23. Cassinotti P, Burtonboy G, Fopp M, Siegl G. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 1997;53(3):229-32.
24. Eis-Hubinger AM, Reber U, Abdul-Nour T, Glatzel U, Lauschke H, Putz U. Evidence for persistence of parvovirus B19 DNA in livers of adults. J Med Virol 2001;65(2):395-401.
25. Manaresi E, Gallinella G, Zuffi E, Bonvicini F, Zerbini M, Musiani M. Diagnosis and quantitative evaluation of parvovirus B19 infections by real-time PCR in the clinical laboratory. J Med Virol 2002:s67(2):275-81.